Company news
PolyNovo Limited news in 2016
PolyNovo Limited's news releases, calls and decks from 2016, newest first.
First stock purchase
December 21, 2016
PolyNovos South Africa Market Entry
December 8, 2016
S&P DJ Indices Announces March Quarterly Review
November 7, 2016
US Market Entry-PolyNovo
October 2, 2016
Full Year Statutory Accounts and Appendix 4E
August 22, 2016
Financial result guidance
August 7, 2016
BTM use in Diabetes Islet Cell Transplantation Study
July 24, 2016
Additional BARDA Option Exercised Valued at US$2.4m
May 31, 2016
US Regulatory Update
March 30, 2016
NovoSkin awarded BioInnovationSA Grant
March 30, 2016
Feasibility Study Extended by 12 Months
March 30, 2016
CZD: Termination of Metabolic vend-in proposal
March 30, 2016
PolyNovo US Patent Allowed
March 30, 2016
PolyNovo US Collaboration Update
March 30, 2016
Polynovo to Commence First Human Trial
March 30, 2016
PolyNovo Human Trial Update
March 30, 2016
Polynovo Completes Pivotal Study on Burns
March 30, 2016
PolyNovo Clinical Trials Update
March 30, 2016
First PolyNovo Patent Allowed in US
March 30, 2016
Trading halt and request
March 30, 2016
Topical Negative Pressure Human Trial Completed
March 30, 2016
Positive Results from NovoSorb Human Clinical Trial
March 30, 2016
AOD9604 Positive in Osteoarthritis Animal Model
March 30, 2016
RAH Surgeons Receive Approval to use BTM
March 30, 2016
PolyNovo Receives CE Mark Approval for NovoPore
March 30, 2016
Financial Result Guidance
February 11, 2016
VAC Human Clinical Trial Update
February 10, 2016
US FDA approval
February 10, 2016
US BARDA Contract Application and BTM Trial Update
February 10, 2016
Update on US Partner Collaboration
February 10, 2016
Successful Proof of Concept for Synthetic Skin
February 10, 2016
Successful Clinical Trial Outcomes for NovoSorb BTM
February 10, 2016
Significant Organisational Structure Initiatives
February 10, 2016
Share Purchase Plan
February 10, 2016
Response to Media Speculation
February 10, 2016
Response to ASX Price and Volume Query
February 10, 2016
R and D Tax Refund Received
February 10, 2016
Preliminary Final Report
February 10, 2016
Polynovo Update
February 10, 2016
PolyNovos US FDA approval
February 10, 2016
PolyNovo Receives FDA 510k Clearance
February 10, 2016
PolyNovo Partners in the Field of Aesthetic Facial Surgery
February 10, 2016
PolyNovo Divests AOD9604
February 10, 2016
PolyNovo Concludes Recruitment for VAC Trial
February 10, 2016
PolyNovo completes acquisition of minorities
February 10, 2016
PolyNovo Commences Second Human Trial
February 10, 2016
PolyNovo Burn Trial Receives Ethics Approval at The Alfred
February 10, 2016
PolyNovo Awarded BARDA Contract for Burns Trial
February 10, 2016
PolyNovo acquires minority interests
February 10, 2016
POH: Phosphagenics to launch new cellulite cosmetics
February 10, 2016